| |
| |
|
| Insider
Information: |
Vogelbaum Martin |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
109,712 |
|
|
Indirect Shares
|
8,609,958 |
|
|
| Direct
Value |
$82,887 |
|
|
|
Indirect Value
|
$2,317,917 |
|
|
| Total
Shares |
8,719,670 |
|
|
| Total
Value |
$2,400,804 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -90.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Middlebrook Pharmaceuticals Corp |
MBRKQ |
Director, 10% Owner |
|
0 |
2007-04-20 |
4,215,075 |
Premium* |
|
|
Cara Therapeutics, Inc. |
CARA |
Director |
2023-06-01 |
109,712 |
2019-06-04 |
3,068,057 |
Premium* |
|
|
Nephrogenex, Inc. |
NRX |
Director |
2014-02-14 |
0 |
2014-02-14 |
1,326,826 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
64,724 |
109,712 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2022-09-14 |
4 |
S |
$10.28 |
$111,024 |
D/D |
(10,800) |
44,988 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
35,628 |
55,788 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2021-06-07 |
4 |
AS |
$13.05 |
$112,752 |
D/D |
(8,640) |
20,160 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
28,800 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-11-17 |
4 |
S |
$16.09 |
$96,540 |
D/D |
(6,000) |
14,400 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
20,400 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2019-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2016-03-17 |
4 |
B |
$4.93 |
$1,221,368 |
I/I |
247,727 |
3,068,057 |
2.1 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2016-03-16 |
4 |
B |
$4.78 |
$727,834 |
I/I |
152,273 |
2,820,330 |
2.1 |
- |
|
| NRX |
Nephrogenex, Inc. |
Director |
– • – |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
180,997 |
1,326,826 |
0 |
- |
|
| NRX |
Nephrogenex, Inc. |
Director |
– • – |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,145,829 |
1,145,829 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2014-02-05 |
4 |
B |
$11.00 |
$2,483,998 |
I/I |
225,818 |
2,668,057 |
2.1 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2014-02-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,442,239 |
2,442,239 |
0 |
- |
|
| MBRKQ |
Middlebrook Pharmaceutica... |
Director |
– • • |
2007-04-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,215,075 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
